Targeting Hsp90 with cemdomespib reduces seizure burden and alters disease course in preclinical epilepsy models

Documenti analoghi

• Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice
  di: Yara Sheeni, et al.
  Pubblicazione: (2025)
• Voluntary running wheel activity reduces seizure burden and affords neuroprotection in a mouse model of acquired epilepsy
  di: Valentina Kebede, et al.
  Pubblicazione: (2025)
• Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches
  di: Teresa Ravizza, et al.
  Pubblicazione: (2025)
• Characterizing the burden of healthcare utilization and expenditure for epilepsy and unclassified seizures in the U.S., 2016–2022
  di: Pooja M. Rajadhyaksha, et al.
  Pubblicazione: (2025)
• Intestinal dysbiosis alters acute seizure burden and antiseizure medicine activity in Theiler's virus model of encephalitis
  di: Inga Erickson, et al.
  Pubblicazione: (2025)